BRIEF-Novavax Announces Improved Terms For Collaboration, License Agreement With Takeda For Nuvaxovid In Japan

Reuters
05 May
BRIEF-Novavax Announces Improved Terms For Collaboration, License Agreement With Takeda For Nuvaxovid In Japan

May 5 (Reuters) - Novavax Inc NVAX.O:

  • NOVAVAX ANNOUNCES SIGNIFICANTLY IMPROVED TERMS FOR COLLABORATION AND LICENSE AGREEMENT WITH TAKEDA FOR NUVAXOVID® IN JAPAN

  • NOVAVAX INC - NUVAXOVID TO REMAIN AVAILABLE IN JAPAN

  • NOVAVAX INC - UPDATED AGREEMENT INCLUDES UPFRONT PAYMENT AND ANNUAL MILESTONES RELATED TO REGULATORY APPROVALS & ROYALTIES ON NET SALES EARNED

Source text: ID:nPn6KMfWxa

Further company coverage: NVAX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10